Kevin P. Claffey

14.0k citations

98 papers · 11.7k indexed · 3 hit papers · h-index 52

Molecular Biology top 0.5%
Oncology top 0.5%
Cancer Research top 0.5%
Immunology top 2%
Cell Biology top 1%

Co-authors: Michael Detmar Harold F. Dvorak Lawrence F. Brown Donald R. Senger Paula Velasco Timothy Hla Shu‐Ching Shih Kathryn N. Phoenix
Topics: Angiogenesis and VEGF in Cancer (29 papers)Cancer, Hypoxia, and Metabolism (28 papers)Cell Adhesion Molecules Research (10 papers)
Cited by: Cancer Research Immunology and Allergy Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States United Kingdom France

In The Last Decade

Kevin P. Claffey

97 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

2001 1.4k citations Kevin P. Claffey, Michael Detmar et al. profile →
Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate

1999 864 citations Shobha Thangada, Kevin P. Claffey et al. Cell profile →
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

1994 574 citations Michael Detmar, Lawrence F. Brown et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Kevin P. Claffey

Since Specialization

Citations

This map shows the geographic impact of Kevin P. Claffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Claffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Claffey more than expected).

Fields of papers citing papers by Kevin P. Claffey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Claffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Claffey. The network helps show where Kevin P. Claffey may publish in the future.

Co-authorship network of co-authors of Kevin P. Claffey

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Claffey. A scholar is included among the top collaborators of Kevin P. Claffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Claffey. Kevin P. Claffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PLCβ2 Promotes VEGF-Induced Vascular Permeability 2022 ·Arteriosclerosis Thrombosis and Vascular Biology ·Kathryn N. Phoenix,Zhichao Yue,Lixia Yue,Chunxia Cronin,Bruce T. Liang,Luke H. Hoeppner,Kevin P. Claffey	16
2	Overcoming hypoxia-induced chemoresistance to cisplatin through tumor oxygenation monitored by optical imaging 2019 ·Nanotheranostics ·Donghui Song,André O’Reilly Beringhs,Zhenwu Zhuang,Gaurav N. Joshi,Thanh Huyền Trần,Kevin P. Claffey,Hong Yuan,Xiuling Lü	26
3	Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer 2018 ·Oncogene ·(unknown),Daniel Kita,Anna Konstorum,Lia Tesfay,(unknown),Poornima Hegde,Kevin P. Claffey,Frank M. Torti,Suzy V. Torti	45
4	AMPKα2 Regulates Bladder Cancer Growth through SKP2-Mediated Degradation of p27 2016 ·Molecular Cancer Research ·(unknown),(unknown),Isha Garg,John A. Taylor,Kevin P. Claffey	18
5	AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms 2016 ·Translational Oncology ·(unknown),Poornima Hegde,John A. Taylor,Kevin P. Claffey	12
6	High-Dose Eicosapentaenoic Acid and Docosahexaenoic Acid Supplementation Reduces Bone Resorption in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors: A Pilot Study 2013 ·Nutrition and Cancer ·Heather Hutchins-Wiese,Katherine Picho,Bruce A. Watkins,Yong Li,Susan Tannenbaum,Kevin P. Claffey,Rose Anne Kenny	49
7	AMP-Activated Protein Kinase 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling 2013 ·Genes & Cancer ·(unknown),Kathryn N. Phoenix,(unknown),Kevin P. Claffey	64
8	Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization 2012 ·PLoS ONE ·Christina Grant,Leslie A. Caromile,Khayyam Durrani,Mamunur Rahman,Kevin P. Claffey,Guo‐Hua Fong,Linda H. Shapiro	40
9	Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs 2011 ·Breast Cancer Research and Treatment ·Irene K. Guttilla Reed,Kathryn N. Phoenix,(unknown),Jennifer S. Tirnauer,Kevin P. Claffey,B A White	121
10	Genomic differences between estrogen receptor (ER)‐positive and ER‐negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis 2010 ·Cancer ·Min Fang,(unknown),Martin Morgan,Jerry Davison,Susan Tannenbaum,Kevin P. Claffey	26
11	Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy 2009 ·Breast Cancer Research and Treatment ·Kathryn N. Phoenix,(unknown),(unknown),Rebecca Evans,Kevin P. Claffey	74
12	Double-Stranded RNA-Binding Protein Regulates Vascular Endothelial Growth Factor mRNA Stability, Translation, and Breast Cancer Angiogenesis 2007 ·Molecular and Cellular Biology ·(unknown),Kathryn N. Phoenix,Daniel Rodríguez‐Pinto,David K. Han,Kevin P. Claffey	101
13	Proteomics Analysis of Human Coronary Atherosclerotic Plaque 2007 ·Molecular & Cellular Proteomics ·Carolina Bagnato,Jaykumar Thumar,Viveka Mayya,Sun‐Il Hwang,Henry Zebroski,Kevin P. Claffey,Christian C. Haudenschild,Jimmy K. Eng,Deborah H. Lundgren,David K. Han	126
14	Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF Expression 2001 ·Growth Factors ·(unknown),Kevin P. Claffey	95
15	Fibroblast Growth Factor 2 Activation of Stromal Cell Vascular Endothelial Growth Factor Expression and Angiogenesis 2001 ·Laboratory Investigation ·Kevin P. Claffey,(unknown),Shu‐Ching Shih,Lawrence F. Brown,Andrew R. Mullen,Martin P. Keough	82
16	Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphatebreakdown → 1999 ·Cell ·(unknown),Shobha Thangada,Kevin P. Claffey,Nicolas Ancellin,Catherine H. Liu,Michael Kluk,Mario Volpi,R.I. Sha’afi,Timothy Hla	864
17	Role of Protein Kinase C Isoforms in Phorbol Ester-induced Vascular Endothelial Growth Factor Expression in Human Glioblastoma Cells 1999 ·Journal of Biological Chemistry ·(unknown),Andrew R. Mullen,(unknown),Debabrata Mukhopadhyay,Kevin P. Claffey	88
18	Identification of a Human VPF/VEGF 3′ Untranslated Region Mediating Hypoxia-induced mRNA Stability 1998 ·Molecular Biology of the Cell ·Kevin P. Claffey,Shu‐Ching Shih,Andrew R. Mullen,Suzan Dziennis,(unknown),(unknown),Sam W. Lee,Michael Detmar	151
19	Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression 1998 ·The Journal of Experimental Medicine ·(unknown),Mindy Tsai,Marcus Maurer,Masao Yamaguchi,Lawrence F. Brown,Kevin P. Claffey,Harold F. Dvorak,Stephen J. Galli	268
20	Vascular permeability factor/vascular endothelial growth factor:A multifunctional angiogenic cytokine 1997 ·Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions ·Lawrence F. Brown,Michael Detmar,Kevin P. Claffey,Janice A. Nagy,D. Feng,Ann M. Dvořàk,Harold F. Dvorak	401

About Kevin P. Claffey

Kevin P. Claffey is a scholar working on Cancer Research, Immunology and Allergy and Molecular Biology, having authored 98 papers that have together received 11.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (29 papers), Cancer, Hypoxia, and Metabolism (28 papers) and Cell Adhesion Molecules Research (10 papers). The work is most often cited by research in Cancer Research (2.5k citations), Immunology and Allergy (919 citations) and Molecular Biology (7.6k citations). Kevin P. Claffey has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Michael Detmar, Harold F. Dvorak, Lawrence F. Brown, Donald R. Senger, Paula Velasco, Timothy Hla, Shu‐Ching Shih, Kathryn N. Phoenix, Lucia Riccardi and Mihaela Skobe. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact